The purpose of the review was to ensure the NCSP is of the highest possible quality, and continues to reduce rates of cervical cancer, and the number of women who die from it.
The following Review Committee members were appointed by Cabinet:
- Ms Gail Ward (Chair), who offers expertise in cancer screening programme management
- Professor Ian Hammond, who offers expertise in gynaecological oncology and implementation of HPV screening
- Ms Liane Penney, who offers extensive experience in Māori health and equity research and evaluation.
The review was completed in April 2019 and the Committee's report is available below, along with earlier reports.
In this section
The third Parliamentary Review Committee for the National Cervical Screening Programme (NCSP) was undertaken in the second half of 2018.
The second Parliamentary Review Committee for the National Cervical Screening Programme (NCSP) was undertaken in the first half of 2015.
The National Cervical Screening Programme Review is legislated under Part 4A, Section 112O, of the Health Act 1956.
Following the Ministerial Inquiry into the Under-reporting of Cervical Smear Abnormalities in the Gisborne Region in 2001 (the Gisborne Inquiry), the legislation governing the NCSP was amended.